Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$243.64 - $270.48 $194,912 - $216,384
-800 Closed
0 $0
Q4 2021

Jan 05, 2022

BUY
$230.08 - $250.94 $184,064 - $200,752
800 New
800 $201,000
Q3 2021

Oct 08, 2021

SELL
$232.72 - $256.47 $577,145 - $636,045
-2,480 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$232.65 - $254.58 $16,285 - $17,820
-70 Reduced 2.75%
2,480 $603,000
Q4 2020

Jan 07, 2021

SELL
$221.92 - $245.94 $44,384 - $49,188
-200 Reduced 7.27%
2,550 $638,000
Q3 2020

Oct 08, 2020

SELL
$215.77 - $276.76 $237,347 - $304,436
-1,100 Reduced 28.57%
2,750 $640,000
Q2 2020

Jul 15, 2020

BUY
$219.9 - $263.41 $434,302 - $520,234
1,975 Added 105.33%
3,850 $921,000
Q1 2020

Jun 15, 2020

BUY
$195.69 - $279.01 $366,918 - $523,143
1,875 New
1,875 $431,000
Q3 2019

Nov 04, 2019

SELL
$230.58 - $256.08 $752,843 - $836,101
-3,265 Closed
0 $0
Q2 2019

Jul 09, 2019

SELL
$217.4 - $246.08 $70,655 - $79,976
-325 Reduced 9.05%
3,265 $823,000
Q1 2019

Apr 03, 2019

SELL
$206.05 - $248.17 $41,210 - $49,634
-200 Reduced 5.28%
3,590 $897,000
Q4 2018

Jan 11, 2019

BUY
$204.73 - $257.93 $775,926 - $977,554
3,790 New
3,790 $854,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.